Author Information
William Chun Hahn is affiliated with several prestigious institutions including the Dana-Farber Cancer Institute in Boston, MA, USA, the Broad Institute of Harvard and MIT in Cambridge, MA, USA, and Brigham and Women's Hospital in Boston, MA, USA. His research primarily focuses on cancer biology and translational medicine, particularly in the areas of genetic and molecular mechanisms underlying cancer progression and treatment resistance.
Research Contributions
William Chun Hahn has made significant contributions to the field of cancer research. In 2022 alone, he published multiple influential papers exploring various aspects of cancer biology, including the role of PI3K activation in immune evasion, the use of Perturb-seq for phenotyping coding variants in cancer, and the identification of therapeutic vulnerabilities in ovarian cancer. His work has advanced the understanding of how genetic and molecular alterations contribute to cancer and has identified potential targets for new therapeutic strategies.
Aliases
William Chun Hahn is also known by several aliases including W. Hahn, William C. Hahn, W. C Hahn, and William Hahn. Publication and Citation Metrics
| Metric |
Value |
| Total Citation Count |
78,682 |
| H-index |
134 |
| Paper Count |
580 |
